December tends to be the time of the year where new releases slow down and you’re finally free to catch up on your backlog. Not this year, suckers! This month has been the busiest December for new ...

When you sit down with a game, you make a pact with it: you’ll push the buttons, and it will show you what happens when you do. A lot of games don’t really care to interrogate what that means, to use ...

They may not yet be kings of the swingers, but macaque monkeys can keep time to music and move to the beat. Well, at least two adult macaques can, who were trained by researchers to tap along to ...

All the Latest Game Footage and Images from Carnival Rhythm The protagonist of this story is a girl with a somewhat nasty gaze, Ebihara. As the sun set, she was terribly depressed. Because she’d ...

The Rhythm Room is a Phoenix live music landmark. The bunker-like club along Indian School Road owned by local bluesman Bob Corritore has jumped and jived for 34-plus years. Rhythm Room concerts are ...

I was having a scroll through my Steam library this week, hunting out games I hadn’t played in a hot sec to fill my night. I’m glad I did, because otherwise I would have missed a very exciting piece ...

Rhythm Pharmaceuticals faces a pivotal period, as IMCIVREE awaits potential FDA approval for acquired hypothalamic obesity in December 2025. RYTM's market opportunity could double or triple with AHO ...

Yunyun Syndrome!? Rhythm Psychosis is a rhythm adventure game about a psychotic hikikomori girl—also an avid anonymous poster—who corrupts the world with her severe brain rot from listening to too ...

Ahmad is a video game fanatic. He always carries his PSVita with him wherever he goes so he can play Metal Gear Solid on the go, and his socials are filled with gaming news. He also lifts weights ...

Leadership, like jazz, finds its strength in rhythm, structure, and the space between notes. What if your team's best performance is hiding in the rhythm of your worst meetings? You know the pattern: ...

Rhythm Pharmaceuticals’ push to move obesity patients from jabs to tabs has stayed on beat. A phase 2 trial of the biotech’s next-generation oral candidate hit its primary endpoint, sending the stock ...